Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer

Journal of Urology

Volumn 164, Issue 6, 2000, Pages 2156-2161

  Vis, André N ^a,b   Noordzij, Marinus A ^a,b   Fitoz, Kubilay ^a,b   Wildhagen, Mark F ^a,b   Schröder, Fritz H ^a,b   Van Der Kwast, Theo H ^a,b  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Carcinoma; Disease progression; Prostate

Indexed keywords

CELL CYCLE PROTEIN; HERMES ANTIGEN; KI 67 ANTIGEN; PROTEIN P27; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CELL ADHESION; CELL CYCLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; PROSTATECTOMY; PROTEIN EXPRESSION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0033762814     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)66989-3     Document Type: Article

References (26)

1. Incidence of Cancer in the Netherlands 1994: The Sixth Report of the Netherlands Cancer Registry
2. Combination of prostate-specific antigen, clinical stage, and Gleason-score to predict pathological stage in men with localized prostate cancer: A multi-institutional update
3. Evaluation of a nomogram used to predict the pathological stage of clinically localized prostate carcinoma
4. Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy
5. Prediction of progression following radical prostatectomy - A multivariate analysis of 721 men with long-term follow-up
6. p27(kip1), a cyclin Cdk inhibitor links transforming growth factor-β and contact inhibition to cell cycle arrest
7. Expression of cell-cycle regulators p27kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
8. Decreased levels of the cell-cycle inhibitor p27kip1 protein: Prognostic implications in primary breast cancer
9. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
10. Prognostic significance of p27(kip1) expression in colorectal cancer: A clinical-pathological characterization
11. Loss of cyclin-dependent kinase inhibitor p27kip1 protein in human prostate cancer correlates with tumor grade
12. Loss of cyclin-dependent kinase inhibitor p27kip1 is a novel prognostic factor in localized human prostate adenocarcinoma
13. Association of p27kip1 levels with recurrence and survival in patients with stage C prostate carcinoma
14. Low p27 expression predicts poor disease-free survival in patients with prostate cancer
15. Expression of p27kip1 in prostatic adenocarcinoma
16. Distinct altered patterns of p27kip1 gene expression in benign prostatic hyperplasia and prostatic carcinoma
17. Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy
18. Cell proliferation assessed by Ki-67 immunoreactivity on formalin fixed tissues is a predictive factor for survival in prostate cancer
19. Bcl-2 oncoprotein positivity and high MIB-1 (Ki-67) proliferative rate are independent predictive markers for recurrence in prostate carcinoma
20. Ki-67 labelling index: An independent predictor of progression in prostate cancer treated by radical prostatectomy
21. Angiogenesis p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy
22. Assessment of the biologic markers p53, Ki-67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgery
23. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy
24. Correlation of p34cdc2 cyclin-dependent kinase overexpression, CD44s downregulation, and HER-2/neu oncogene amplification with recurrence in prostatic adenocarcinomas
25. Requirement of p27kip1 for restriction point control of the fibroblast cell cycle
26. p27kip1: A multifunctional cyclin-dependent-kinase inhibitor with prognostic significance in human cancers